StockData

Axsome Therapeutics vs TG Therapeutics

AXSM and TGTX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How AXSM and TGTX compare

TG Therapeutics is the larger company, worth 1.3 times as much as Axsome Therapeutics ($9.6B against $7.1B).

TG Therapeutics grew revenue faster over the last twelve months (76.1% versus 56.9% for Axsome Therapeutics).

TG Therapeutics keeps more of each dollar of sales as profit, with a net margin of 55.2% compared with −24.7% at Axsome Therapeutics.

TG Therapeutics scores higher on the StockData Score (9 against 8 for Axsome Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAXSMTGTX
Size and price
Market cap$7.1B$9.6B
Share price$135.95$62.71
Change, 1 year−2.7%102%
Change, 5 years268%162%
Beta (5Y)0.870.47
Employees500399
StockData Score
Total score89 (better)
Valuation score01 (better)
Growth score3 (better)2
Performance score24 (better)
Health score3 (better)2
Dividend score00
Valuation
P/E–22.9×
P/S9.2× (better)12.0×
P/B85.5×15.9× (better)
EV/EBITDA–71.3×
P/FCF–552×
FCF yield−1.0%0.18% (better)
Fair value–$60.66
Margin of safety–−3.4%
Growth
Revenue growth (TTM)56.9%76.1% (better)
Revenue growth, 5Y average–427%
Net income growth (TTM)–630%
EPS growth (TTM)–641%
Profitability
Gross margin93.2% (better)82.4%
Operating margin−24.0%17.1% (better)
Net margin−24.7%55.2% (better)
FCF margin−9.3%2.2% (better)
Return on equity−245%100% (better)
Return on invested capital–27.8%
Financial health
Debt / equity2.261.23 (better)
Net debt / EBITDA–0.98
Interest coverage–3.6×
Current ratio1.434.27 (better)
Altman Z-score4.216.07 (better)
Piotroski F-score5 (better)4
Dividends and buybacks
Buyback yield−0.50%1.9% (better)
Shareholder yield−0.50%1.9% (better)
Ownership
Held by institutions73.8%72.6%
Held by insiders15.2%16.1%
Insider net buying, 12 months−$113M−$275K (better)
Short interest, % of float7.3%22.4%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.